A list of peer-reviewed publications can be found at:
Research in the Ammons Lab is focused on understanding the mechanisms and clinical outcomes of how metabolism drives macrophage functional plasticity in non-healing wounds. Utilizing a complex systems biology approach, the Ammons Lab investigates genomic, transcriptomic, proteomic, and metabolomic biomarkers to characterize cellular mechanisms of metabolic immunomodulation and facilitate discovery of novel diagnostic and therapeutic targets for non-healing wounds.
In addition, the Ammons Lab has expanded into SARS-CoV-2 research, including genetic epidemiology of viral emergence, social and geographical determinants of variant emergence, host immunity of COVID-19, and characterization of Long/Post-COVID Syndrome. The Ammons Lab runs the VA Sequencing Consortium United for Research and Epidemiology (VA SeqCURE) and VA Science and Health Initiative to combat Infectious Diseases and other Emerging Life-threatening Diseases (VA SHIELD), the national VA initiatives for infectious disease research and biorepository. Through these initiatives the Boise VA has access to a national biospecimen and data repository for emerging infectious disease research.